CEACAM5 and ovarian carcinoma: Carcinoembryonic antigen (CEA), a broad-spectrum cancer biomarker, was used to diagnose a variety of clinical disease, including pancreatic cancer, ovarian cancer, gastric cancer, colorectal cancer [117].